middl
east
respiratori
syndrom
coronaviru
merscov
newli
emerg
zoonot
pathogen
first
identifi
kingdom
saudi
arabia
caus
acut
sever
respiratori
ill
high
mortal
rate
human
septemb
laboratoryconfirm
human
infect
report
world
health
organ
includ
death
case
fatal
rate
although
major
report
case
associ
sporad
outbreak
countri
middl
east
case
occur
outsid
middl
east
region
primarili
link
recent
travel
middl
east
case
includ
unexpect
larg
outbreak
confirm
case
death
south
korea
may
juli
similar
larg
outbreak
saudi
arabia
south
korean
mer
outbreak
mainli
associ
health
care
set
acceler
interhospit
spread
although
earli
genom
analysi
merscov
reveal
respiratori
pathogen
close
relat
bat
coronaviru
belong
genu
betacoronaviru
accumul
evid
support
dromedari
camel
reservoir
host
primari
sourc
human
infect
viral
merscov
spike
protein
suggest
critic
viral
factor
host
tropism
via
interact
host
receptor
evolutionari
pathway
merscov
human
adapt
remain
unclear
efficaci
direct
humantohuman
spread
commun
seem
quit
low
rate
human
transmiss
among
household
contact
mer
patient
approxim
base
serolog
analysi
howev
ongo
sporad
outbreak
highlight
import
earli
nosocomi
superspread
event
secondari
human
infect
activ
case
detect
implement
intervent
also
typic
superspread
event
fuel
unexpect
larg
outbreak
south
korea
index
case
patient
return
middl
east
gener
case
secondari
infect
two
patient
patient
e
second
wave
infect
gener
link
least
case
third
gener
respect
fig
rapid
wide
spread
merscov
south
korean
outbreak
rais
strong
concern
possibl
gener
mutat
enhanc
sequenti
human
infect
studi
analyz
merscov
genom
isol
patient
admit
chungnam
nation
univers
hospit
one
design
nation
safe
hospit
south
korean
outbreak
compar
recent
report
genom
two
south
korean
patient
other
deposit
genbank
databas
transmiss
chain
merscov
timelin
potenti
viral
exposur
symptom
onset
date
genom
collect
patient
admit
chungnam
nation
univers
hospit
present
fig
patient
pool
includ
secondari
infect
case
patient
e
close
contact
index
case
patient
hospit
p
eleven
case
patient
f
g
h
j
k
l
n
p
third
wave
infect
gener
two
case
patient
r
fourth
gener
also
includ
studi
two
patient
f
g
tertiari
case
visit
hospit
least
infect
occur
infect
patient
remain
tertiari
case
patient
h
p
patient
care
giver
hospit
g
case
gener
patient
e
clinic
characterist
patient
includ
incub
period
fever
durat
presenc
pneumonia
summar
tabl
supplement
materi
among
case
patient
complet
recov
patient
expir
fatal
case
includ
femal
four
patient
comorbid
diseas
chronic
obstruct
pulmonari
diseas
liver
cirrhosi
tabl
isol
sequenc
whole
viral
genom
respiratori
secret
patient
fig
genom
sequenc
south
korean
patient
b
c
recent
report
republ
korea
center
diseas
control
prevent
korean
cdc
genbank
access
number
chines
center
diseas
control
prevent
chines
cdc
genbank
access
number
respect
also
analyz
togeth
new
viral
genom
compar
viral
genom
isol
south
korean
patient
merscov
genom
avail
genbank
septemb
genom
coverag
mutat
found
south
korean
isol
fig
see
tabl
supplement
materi
fourteen
mutat
nonsynonym
mutat
result
chang
amino
acid
six
mutat
observ
seven
mutat
observ
protein
one
delet
mutat
caus
frameshift
fusion
four
mutat
detect
one
isol
observ
chang
posit
protein
codon
predict
posit
select
viral
genom
worth
note
mutat
receptorbind
domain
rbd
protein
result
chang
amino
acid
properti
acid
aspart
hydrophob
glycin
g
hydrophob
isoleucin
polar
threonin
respect
moreov
mutat
rbd
especi
emerg
patient
second
gener
patient
e
spread
third
fourth
gener
patient
within
month
fig
thu
assess
whether
nonsynonym
mutat
rbd
protein
affect
interact
cognat
human
receptor
structur
analysi
mutat
locat
interfaci
region
protein
fig
found
mutat
introduc
energet
unfavor
interact
interfac
specif
protein
locat
interfaci
loop
interact
directli
residu
fig
see
tabl
supplement
materi
mutat
disrupt
ionic
interact
moreov
locat
backsid
interfac
fig
tabl
mutat
introduc
polar
side
chain
hydrophob
residu
cluster
therefor
potenti
affect
energet
stabil
interfaci
beta
sheet
rbd
order
quantifi
bind
affin
mutant
rbd
perform
surfac
plasmon
reson
spr
experi
purifi
rbd
protein
fig
studi
wildtyp
rbd
bind
dissoci
constant
kd
nm
kon
koff
slightli
lower
compar
nm
measur
previou
studi
differ
might
due
fix
chip
spr
assay
wherea
rbd
fix
previou
experi
mutant
rbd
bind
kd
nm
kon
koff
almost
time
lower
wildtyp
rbd
case
rbd
bind
kd
nm
kon
koff
almost
time
lower
wildtyp
rbd
expect
structur
predict
confirm
reduc
affin
purifi
rbd
mutant
analyz
bind
cell
stabli
express
see
fig
supplement
materi
flow
cytometri
assay
shown
fig
mutat
rbd
bind
cell
overexpress
differ
efficaci
substitut
increas
effect
concentr
twofold
wherea
rbd
mutant
almost
time
higher
wildtyp
rbd
addit
maximum
bind
two
mutant
rbd
satur
approxim
wildtyp
rbd
final
investig
biolog
relev
mutat
protein
use
pseudotyp
lentiviru
bear
mutant
protein
fig
mutat
protein
significantli
lower
effici
viral
entri
cell
overexpress
compar
viru
bear
wildtyp
protein
basal
level
viral
entri
control
cell
chang
infect
vesicular
stomat
viru
g
protein
vsvg
pseudotyp
viru
significantli
affect
express
host
cell
suggest
reduct
viral
entri
mutat
specif
depend
interact
consid
genet
stabil
protein
merscov
genom
report
thu
far
quit
interest
note
rapid
emerg
subsequ
conserv
rbd
mutat
consecut
human
infect
sinc
gener
thought
interspeci
transmiss
coronavirus
primarili
mediat
mutat
protein
enhanc
affin
toward
human
receptor
unexpect
emerg
wide
spread
rbd
mutat
reduc
affin
human
humantohuman
spread
south
korean
mer
outbreak
rais
sever
critic
question
first
mutat
rate
merscov
may
differ
sequenti
human
spread
base
result
genom
analysi
howev
genom
gener
one
three
nucleotid
chang
see
tabl
supplement
materi
addit
isol
sequenc
two
viral
genom
patient
patient
h
fig
separ
interv
fail
observ
detect
chang
data
shown
also
report
differ
found
nucleotid
sequenc
genom
sampl
singl
patient
taken
day
week
later
second
mutat
rbd
protein
might
gener
better
suit
polymorph
specif
south
korean
popul
inde
shown
differ
interfac
residu
among
host
receptor
differ
mammalian
speci
critic
trigger
interspeci
transmiss
coronaviru
howev
preliminari
analysi
sequenc
encod
interfac
domain
south
korean
patient
fail
show
substanti
differ
data
shown
third
mutat
observ
south
korean
outbreak
could
affect
sever
diseas
caus
mer
sinc
number
patient
whose
viral
genom
current
avail
limit
direct
demonstr
correl
yet
possibl
could
distinguish
specif
correl
use
epidemiolog
clinic
inform
case
list
tabl
supplement
materi
function
analys
mutat
fig
viral
pathogenesi
infect
need
perform
consid
case
fatal
rate
south
korean
outbreak
lower
overal
mortal
rate
mer
case
spread
rbd
mutat
reduc
affin
human
receptor
well
earlier
diagnosi
quarantin
outbreak
potenti
associ
milder
consequ
although
differ
health
care
set
among
nation
mer
endem
need
taken
account
make
direct
comparison
addit
mutat
protein
delet
three
nucleotid
expir
patient
k
lead
fusion
fig
tabl
notabl
sinc
protein
known
function
antagonist
type
interferon
signal
final
reduc
affin
host
receptor
rbd
mutat
link
transmiss
merscov
viral
mutat
select
maintain
humantohuman
transmiss
current
abl
calcul
compar
reproduct
rate
merscov
infect
south
korean
outbreak
due
limit
avail
inform
patient
infect
mutant
virus
howev
avail
gene
sequenc
isol
korean
patient
reveal
patient
includ
three
superspread
patient
infect
merscov
carri
mutat
protein
fig
remark
wildtyp
rbd
sequenc
found
sever
second
thirdgener
patient
mutat
found
two
patient
third
fourth
gener
fig
origin
viru
carri
index
patient
may
carri
mutat
may
convert
wildtyp
mutant
virus
bear
mutat
protein
humantohuman
spread
order
elucid
evolutionari
pathway
gene
mutat
sequenti
human
infect
moredetail
analysi
need
conduct
use
genom
sequenc
isol
south
korean
patient
nevertheless
shown
south
korean
outbreak
follow
progress
similar
previous
describ
hospit
cluster
involv
coronavirus
earli
superspread
event
gener
disproportion
larg
number
secondari
tertiari
infect
transmiss
potenti
diminish
greatli
subsequ
gener
thought
human
adapt
anim
coronaviru
might
achiev
sequenti
mutat
enhanc
affin
protein
human
receptor
demonstr
sever
acut
respiratori
syndrom
coronaviru
sarscov
evolut
howev
result
current
studi
show
rapid
wide
spread
rbd
mutant
reduc
affin
human
receptor
gener
evid
support
hypothesi
interestingli
previou
report
show
neutral
antibodi
merscov
may
contribut
merscov
clearanc
also
viral
evolut
treatment
neutral
antibodi
vitro
infect
media
gener
sever
escap
mutat
rbd
merscov
major
escap
mutat
neg
impact
receptor
bind
viral
fit
line
observ
current
studi
shown
rbd
mutat
gener
neutral
antibodi
pressur
decreas
rbd
bind
affin
result
profound
loss
neutral
antibodi
bind
activ
base
result
propos
immunodomin
human
neutral
antibodi
respons
interfac
restrict
merscov
evolut
drive
viru
escap
pathway
predominantli
result
signific
cost
viral
fit
consid
mutat
emerg
conserv
major
viral
genom
isol
south
korean
patient
fig
natur
variat
reduc
affin
may
also
produc
respons
neutral
antibodi
exert
vivo
select
pressur
decreas
virul
neutral
escap
mutant
also
coincid
reduc
affin
mutant
sar
protein
receptor
analysi
interact
neutral
antibodi
gener
infect
patient
mutant
virus
need
conduct
confirm
hypothesi
merscov
genom
sequenc
obtain
patient
respiratori
sampl
ethic
approv
grant
institut
review
board
chungnam
nation
univers
hospit
seoul
nation
univers
hospit
clinic
sampl
collect
viral
diagnosi
consent
patient
use
viral
sequenc
analysi
ethic
approv
procedur
approv
institut
review
board
patient
recov
provid
written
inform
consent
particip
case
patient
die
obtain
exempt
patient
consent
analysi
viral
sequenc
institut
review
board
chungnam
nation
univers
hospit
seoul
nation
univers
hospit
nucleic
acid
extract
pcrconfirm
mer
patient
process
revers
transcript
pcr
amplif
use
modifi
version
method
describ
previous
briefli
rna
extract
sputum
tracheal
aspir
sampl
use
trizol
ls
reagent
thermo
fisher
scientif
accord
manufactur
instruct
merscov
rna
genom
convert
dna
amplifi
pcr
overlap
amplicon
use
primer
set
list
tabl
supplement
materi
amplicon
gel
purifi
sequenc
directli
use
dna
analyz
appli
biosystem
contig
assembl
use
seqman
version
dnastar
lasergen
usa
new
genom
align
publish
merscov
genom
use
muscl
softwar
complex
structur
merscov
spike
rbd
bound
pdb
identif
id
access
number
use
analyz
effect
mutat
mutat
highlight
use
pymol
http
wwwpymolorg
foldx
http
foldxcrg
use
calcul
chang
energet
stabil
residu
wildtyp
mutant
rbd
structur
interfaci
residu
rbd
identifi
chang
solventaccess
surfac
area
sasa
greater
upon
format
complex
sasa
residu
calcul
use
naccess
contact
particular
residu
identifi
use
csu
softwar
http
liginweizmannacillpccsu
human
merscov
rbd
wildtyp
mutant
protein
use
surfac
plasmon
reson
experi
prepar
use
bactobac
baculoviru
express
system
invitrogen
life
technolog
residu
merscov
rbd
spike
residu
wild
type
kindli
provid
georg
f
gao
clone
vector
contain
signal
peptid
n
terminu
protein
secret
hexahistidin
tag
c
terminu
protein
purif
two
merscov
rbd
mutant
gener
use
quikchang
kit
stratagen
rbd
construct
express
spodoptera
frugiperda
insect
cell
secret
form
collect
cultur
day
centrifug
remov
cell
media
concentr
adjust
ph
purif
protein
purifi
use
ml
histrap
hp
column
ge
healthcar
wash
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
elut
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
final
protein
load
onto
superdex
column
ge
healthcar
equilibr
mm
trishcl
ph
mm
nacl
check
homogen
spr
experi
perform
use
machin
chip
biorad
pbst
phosphatebuff
salin
contain
tween
buffer
mm
ph
mm
kcl
mm
nacl
volvol
tween
use
throughout
spr
experi
protein
immobil
chip
approxim
respons
unit
rbd
protein
wildtyp
protein
mutant
protein
gradient
concentr
nm
prepar
pass
chip
surfac
end
cycl
chip
surfac
regener
mm
glycinehcl
ph
langmuir
bind
model
use
analyz
bind
kinet
rbd
wild
type
protein
fulllength
human
protein
ctermin
hemagglutinin
ha
tag
clone
pefiresp
vector
express
puromycin
resist
gene
via
intern
ribosom
entri
site
sequenc
overexpress
cell
confirm
flow
cytometri
analysi
use
antihuman
antibodi
biolegend
transfect
plasmid
construct
select
puromycin
see
fig
supplement
materi
bind
examin
flow
cytometri
analysi
purifi
wildtyp
mutant
rbd
protein
serial
dilut
incub
cell
overexpress
dulbecco
modifi
eagl
medium
dmem
incub
h
cell
wash
three
time
phosphatebuff
salin
pb
stain
rabbit
antihi
antibodi
santa
cruz
antirabbit
igg
conjug
alexa
fluor
life
technolog
flow
cytometr
analysi
pseudotyp
viru
gener
cell
invitrogen
cotransfect
human
immunodefici
viru
backbon
plasmid
express
firefli
luciferas
describ
previous
use
packag
plasmid
plpvsvg
invitrogen
luc
stand
luciferas
ire
stand
intern
ribosom
entri
site
clontech
sprotein
pseudotyp
fulllength
cdna
gene
sino
biolog
inc
clone
use
transfect
instead
plpvsvg
plasmid
carri
gene
encod
mutat
protein
gener
use
quikchang
kit
stratagen
base
wildtyp
construct
point
mutat
confirm
sequenc
viral
supernat
harvest
h
transfect
normal
enzymelink
immunosorb
assay
elisa
kit
clontech
infect
cell
viral
entri
assay
infect
cell
lyse
h
infect
effici
viral
entri
measur
compar
luciferas
activ
pseudotyp
virus
bear
wildtyp
mutant
protein
vsvgpseudotyp
lentiviru
use
posit
control
rel
luciferas
activ
cell
lysat
measur
use
luciferas
assay
kit
promega
infinit
pro
micropl
reader
tecan
